bluebird bio Inc (BLUE)
0.4638
0.00 (0.00%)
USD |
NASDAQ |
Nov 04, 16:00
0.475
+0.01
(+2.41%)
After-Hours: 20:00
bluebird bio Gross Profit Margin (Quarterly): -79.78% for June 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | -79.78% |
March 31, 2024 | -39.26% |
December 31, 2023 | -22.95% |
September 30, 2023 | 11.60% |
June 30, 2023 | 2.80% |
March 31, 2023 | -131.5% |
December 31, 2022 | 66.67% |
September 30, 2022 | |
June 30, 2022 | -14.88% |
March 31, 2022 | -327.2% |
December 31, 2021 | -129.2% |
September 30, 2021 | -1.80K% |
June 30, 2021 | -10.54K% |
March 31, 2021 | 35.57% |
December 31, 2020 | 98.38% |
Date | Value |
---|---|
September 30, 2020 | 93.16% |
June 30, 2020 | 99.22% |
March 31, 2020 | 95.31% |
December 31, 2019 | 94.51% |
September 30, 2019 | 90.33% |
June 30, 2019 | 95.39% |
March 31, 2019 | 96.55% |
December 31, 2018 | 95.75% |
September 30, 2018 | 99.75% |
June 30, 2018 | 99.73% |
March 31, 2018 | 99.89% |
December 31, 2017 | 99.83% |
September 30, 2017 | 85.73% |
June 30, 2017 | 97.49% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-10.54K%
Minimum
Jun 2021
99.22%
Maximum
Jun 2020
-693.9%
Average
-6.04%
Median
Gross Profit Margin (Quarterly) Benchmarks
Perspective Therapeutics Inc | -- |
Protalix BioTherapeutics Inc | 29.82% |
Predictive Oncology Inc | 45.12% |
Spectral AI Inc | 44.32% |
Vertex Pharmaceuticals Inc | 85.94% |
Gross Profit Margin (Quarterly) Related Metrics
Return on Equity | -174.9% |
Return on Assets | -50.68% |
Return on Invested Capital | -151.3% |
Profit Margin (Quarterly) | -505.5% |
Operating Margin (Quarterly) | -549.0% |
Return on Net Operating Assets | -87.23% |